Novel agents and new combination treatments on phase I studies on solid tumors and pancreatic cancer
Pancreatic cancer is a relatively rare malignancy with a very aggressive natural course, not
restrained by the existing current treatments. At the 2012 American Society of Clinical …
restrained by the existing current treatments. At the 2012 American Society of Clinical …
Therapeutic Cancer Vaccines
C Heery, A Tesfaye, B Weinberg, J Marshall - … for Gastrointestinal Cancer, 2017 - Springer
Immune therapy for cancer has evolved significantly in the past several decades. With the
recent dramatic successes of novel immune modulating agents in certain cancers, the …
recent dramatic successes of novel immune modulating agents in certain cancers, the …
Vaccine therapy in pancreatic cancer
BA Weinberg, MJ Pishvaian - Current and Emerging Therapies in …, 2018 - Springer
Pancreatic adenocarcinoma is an aggressive malignancy associated with poor overall
survival. There is a dire need for novel targeted agents to add to the armamentarium of …
survival. There is a dire need for novel targeted agents to add to the armamentarium of …